|
||
Original Article |
ferric.fang{at}uchsc.edu
| Abstract |
|---|
|
|
|---|
appears to augment antibacterial activity predominantly by enhancing NO· production, although a small iNOS-independent effect was also observed. These findings demonstrate that macrophages kill Salmonella in a dynamic process that changes over time and requires the generation of both reactive oxidative and nitrosative species.
Key Words: phagocyte Salmonella innate immunity nitrosative oxidative
Radicals generated by the NADPH oxidase and inducible nitric oxide (NO) synthase (iNOS) are cytotoxic for a variety of microorganisms as phylogenetically diverse as viruses, bacteria, protozoa, and fungi. The NADPH oxidase expressed by myeloid cells catalyzes the univalent reduction of molecular oxygen to O2·–. This radical has only limited membrane diffusibility and modest antibacterial activity, but also serves as a precursor to more toxic reactive oxygen species (ROS [6]). The critical role of the phagocyte oxidase (phox) is reflected by the enhanced susceptibility of patients with chronic granulomatous disease to a wide range of microbial pathogens, including Salmonella species 678. Immunodeficient gp91phox–/– mice, an animal model for X-linked chronic granulomatous disease (CGD), are accordingly very susceptible to experimental Salmonella typhimurium infections 910. The reduced killing capacity of cell lines impaired in their ability to sustain a respiratory burst further attests to the importance of the NADPH oxidase in the anti-Salmonella activity of macrophages 11.
NOS isoforms generate NO· in a complex reaction that consumes NADPH, oxygen, and L-arginine 12. NO· by itself posses only weak antimicrobial activity against Salmonella 13, but congeners resulting from NO· autooxidation such as NO2·, N2O3, and S-nitrosothiols 14 enhance its cytotoxic potential. In addition, concerted actions of the NADPH oxidase and iNOS can synergize to form highly potent antimicrobial species. For example, NO· reacts at a rate of 6.7 x 109 M/s with O2·– to form ONOO– 1516, an oxidant capable of damaging lipids, proteins, and DNA; ONOO– has been associated with enhanced killing of S. typhimurium, Escherichia coli, and Candida albicans 131718. NO· can also act in concert with H2O2 to kill E. coli in vitro by a mechanism that appears to be at least partially iron dependent 19.
The contribution of NO· is of particular significance in resistance to intracellular pathogens. Development of a Th1 immune response dominated by IFN-
In this work, we employed macrophages from C57BL/6 mice and their congenic iNOS–/–, gp91phox–/–, and doubly immunodeficient iNOS–/–gp91phox–/– derivatives to elucidate the contributions of the NADPH phagocyte oxidase and iNOS to antibacterial actions of macrophages for wild-type S. typhimurium.
Mice.
Macrophages.
Macrophage Killing Assays.
Chemiluminescence.
Superoxide Anion Determination.
Hydrogen Peroxide Determination.
NOX Determination.
Immunocytochemistry.
![]()
Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Salmonella pathogenesis commences in the ileal mucosa with invasion of M cells or ingestion by CD18-expressing phagocytes 12. For the duration of the infection, Salmonella can be found principally within mononuclear phagocytes 3, which can serve as a vehicle of extraintestinal dissemination 1 and as a protected site for intracellular bacterial replication 3. The capacity to survive within macrophages is an absolute requirement for Salmonella virulence in vivo 4. Macrophages contribute to resistance to Salmonella by forming granulomas and limiting bacterial growth 5, but the effector mechanisms by which mononuclear phagocytes combat this intracellular pathogen are incompletely understood.
, IL-2, and IL-12 synthesis in combination with NO·-mediated effector functions has been correlated with resistance to Leishmania and mycobacterial infections 2021. Similarly, IFN-
, IL-12, and TNF-
production is associated with resistance to S. typhimurium 2223. However, the contribution of NO· in innate immunity to Salmonella is still a matter of active debate. Evidence obtained from several laboratories using several nitrogen oxide donors such as S-nitrosoglutathione, acidified NO2–, and ONOO– has unequivocally established that S. typhimurium is susceptible to reactive nitrogen species (RNS) in vitro 13242526. Furthermore, S. typhimurium deficient in DNA repair systems (e.g., umuC and recBC), small thiol molecules (e.g., homocysteine and glutathione), or detoxifying enzymes (e.g., flavohemoprotein or copper zinc superoxide dismutase) is hypersusceptible to NO· congeners in vitro, and shows reduced macrophage resistance and virulence in vivo 1325272829. Yet, despite this compelling evidence favoring distinct NO· actions against Salmonella, some studies have failed to demonstrate that NO· plays a role in macrophage inhibition or killing of wild-type S. typhimurium 9243031.
![]()
Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
Bacterial Strains.
Wild-type S. typhimurium strains American Type Culture Collection 14028s 1 and M525P 1032 were used for this study. For immunofluorescence microscopy, rpsM::gfp was moved by P22-mediated transduction from strain SMO22 1 into S. typhimurium 14028s to yield S. typhimurium AF991 (gfp+).
Wild-type C57BL/6 mice were purchased from The Jackson Laboratory. Congenic iNOS–/– 33, gp91phox–/– 34, and doubly immunodeficient iNOS –/–gp91phox–/– 9 mice were bred in our animal facility according to Institutional Animal Care and Use Committee guidelines. The iNOS–/– mice were the progeny (N3–N5) of mice backcrossed onto a C57BL/6 background for 10 generations (gift of C. Nathan, Cornell University, New York, NY). The gp91phox–/– and iNOS–/–gp91phox–/– mice were progeny (N4–N6) of mice described previously 934. gp91phox–/– and iNOS–/–gp91phox–/– mice were maintained on drinking water containing 15 mg/ml itraconazole, 0.2 mg/ml trimethoprim, and 40 mg/ml sulfamethoxazole up to 4 d before experimentation to prevent spontaneous infections.
Peritoneal macrophages from C57BL/6 and congenic iNOS–/– 33, gp91phox–/– 34 and doubly immunodeficient iNOS–/–gp91phox–/– 9 mice were harvested 4 d after intraperitoneal inoculation of 1 mg/ml sodium periodate as described 25. The peritoneal exudate cells were resuspended in RPMI 1640 supplemented with 10% heat-inactivated FCS (Gemini Bioproducts), 1 mM sodium pyruvate, 10 mM Hepes, and 2 mM L-glutamine (all reagents from Sigma-Aldrich). The macrophages were selected by adherence in a 96-well plate and cultured for 48 h at 37°C in a 5%-CO2 incubator. Unless otherwise indicated, adherent macrophages were treated in vitro overnight with 20 U/ml of IFN-
(Life Technologies) from a 105 U/ml stock containing 0.8 ng/ml LPS.
Periodate-elicited macrophages were challenged with S. typhimurium opsonized with 10% normal mouse serum at a 10:1 multiplicity of infection, allowed to internalize the bacteria for 15 min, and washed with prewarmed medium containing 6 µg/ml gentamicin 25. At several time points after infection, the macrophages were lysed with 0.5% sodium deoxycholate, and surviving bacteria were enumerated on Luria-Bertani agar plates. The results are expressed as percentage survival.
Macrophage chemiluminescence was estimated by the reduction of 25 µM lucigenin (bis-N-methylacridinium) and the oxidation of 100 µM luminol (5-amino-2,3-dihydro-1,4-phthalazinedione; Sigma-Aldrich) with a Lumistar chemiluminometer (BMG Lab Technologies) in Microlite flat-bottomed microtiter plates (Dinex Technologies, Inc.). The macrophages were challenged with wild-type S. typhimurium American Type Culture Collection 14028s as described in the macrophage killing assays above. Extracellular bacteria were removed by washing and the addition of 6 µg/ml gentamicin. At specified time intervals, medium was harvested and replaced by fresh medium for performance of the assays. Lucigenin and luminol were used as indicators of O2·– and ONOO– production 3536, respectively. 1 mM uric acid 3738 inhibited
80% of luminol-dependent chemiluminescence generated by IFN-
–activated periodate-elicited macrophages 1 h after bacterial challenge, whereas 1,000 U/ml catalase (gift of Dr. S. Libby, North Carolina State University, Raleigh, NC) inhibited only 20%. These observations, along with the dependence of chemiluminescence on both the NADPH oxidase and iNOS, indicate that the majority of this luminol chemiluminescence is mediated by ONOO–, whereas a minor proportion reflects H2O2. Periodate-elicited macrophages from wild-type, iNOS–/–, and phox–/– mice were compared.
O2·– was quantified by the superoxide dismutase–inhibitable reduction of ferricytochrome c 39. At different time points after infection with Salmonella, medium was removed from cultured IFN-
–treated 48 h–aged periodate-elicited macrophages and replaced with fresh medium containing 60 µM ferricytochrome c in phenol red–free Earle's balanced salt solution. After 1 h incubation in 5% CO2 at 37°C, the OD of the supernatants was determined spectrophotometrically at 550 nm. The concentration of O2·– was calculated by using an
550 of 2.1 x 103 M–1 cm–1. All reagents were purchased from Sigma-Aldrich.
H2O2 was measured by the horseradish peroxidase–dependent oxidation of phenol red 39. The macrophages were challenged with Salmonella as described above, and extracellular bacteria were removed by washing and the addition of gentamicin before incubation in Earle's balanced salt solution containing 0.56 mM phenol red and 20 U/ml horseradish peroxidase. At indicated time intervals, medium was harvested and replaced with fresh medium. After 1 h incubation at 37°C in a 5%-CO2 atmosphere, the absorbance of the supernatants was read at 600 nm after mixing with 10 µl of 1 N NaOH per well. H2O2 was quantitated by comparison with a standard curve prepared with known concentrations of H2O2. All reagents were purchased from Sigma-Aldrich.
NO synthesis by periodate-elicited macrophages challenged with Salmonella as described above was estimated by measuring the accumulation of nitrite (NO2–) and nitrate (NO3–), stable metabolites of the reaction of NO with oxygen, using the Griess reaction. The NO2– present in supernatants of Salmonella-infected macrophages was measured spectrophotometrically at 550 nm after mixing with an equal volume of Griess reagent (0.5% sulfanilamide and 0.05% N-1-naphthylethylenediamide hydrochloride in 2.5% acetic acid). The NO2– concentration was determined from a standard curve prepared with NaNO2. The NO3– accumulated in the supernatants was estimated by the Griess reaction after enzymatic reduction of NO3– to NO2– 4041 in pH 7 sodium phosphate buffer containing 1.6 U/ml nitrate reductase, 16 U/ml glucose dehydrogenase, 10 µM NADPH, and 10 mM glucose-6-phosphate. NO3– concentration was calculated as the difference between NO2– accumulated in the presence and absence of nitrate reductase. At designated time points, the NOX concentrations were determined from S. typhimurium–challenged macrophages cultured for 1 h in serum-free IMDM (Sigma-Aldrich) supplemented with 7.5% minimal essential amino acid solution (Life Technologies), 1% minimal nonessential amino acid solution, 1.1 mM sodium pyruvate (Life Technologies), 1 mg/ml streptomycin sulfate (Sigma-Aldrich), 0.5 mg/ml gentamicin (Sigma-Aldrich), 0.6 mg/ml penicillin G (Life Technologies), 0.75% wt/vol dextrose (Sigma-Aldrich), 0.85% wt/vol NaHCO3 (Sigma-Aldrich), and 1% nutridoma-SP (Boehringer). Low background levels of nitrate (
1 µM) detected in parallel wells were subtracted to exclude a contribution by residual levels of nitrate present in the culture medium.
Macrophages plated onto sterile coverslips were incubated for 48 h at 37°C in a 5%-CO2 atmosphere. The macrophages were stimulated with IFN-
during the last 20 h and challenged with S. typhimurium strain 14028s as described above. After 90 min of infection, the coverslips were washed with PBS, and the cells were fixed with 2% paraformaldehyde in PBS for 20 min. After extensive washing with 0.1% Tween in PBS, the macrophages were incubated with a 3% normal goat serum solution in Tris balanced solution, pH 7.3. The cells were stained with 5 µg/ml of a rabbit antinitrotyrosine polyclonal antibody 42 or a rabbit antidinitrophenol (Zymed Laboratories) polyclonal control antibody for 1 h, followed by a rhodamine-conjugated goat anti–rabbit polyclonal antibody (Jackson ImmunoResearch Laboratories) for 1 h. After washing, the coverslips were mounted with Vectashield® (Vector Laboratories) and examined with an Olympus IX70 inverted microscope, a Photometrics PXL camera with Kodak KAF1400 chip (6.7 x 6.7 µm physical pixels giving 67 nm per image pixel with a x100 oil immersion objective), and a Silicon Graphic O2 computer with DeltaVision deconvolution software (Applied Precision).
![]()
Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
NADPH Oxidase– and iNOS-derived Chemical Species Contribute to the Antimicrobial Activity of Macrophages for Salmonella.
Macrophages from iNOS–/– or gp91phox–/– mice exerted less antimicrobial activity to S. typhimurium strain 14028s than macrophages from congenic wild-type control animals (Fig. 1). Macrophages lacking the NADPH oxidase were less effective in their ability to contain Salmonella than congenic cells lacking iNOS, suggesting that O2·– or its derivatives play a greater role than NO· congeners in Salmonella killing (Fig. 1). The addition of IFN-
enhanced bactericidal activity of wild-type macrophages (Fig. 1), and this was correlated with enhanced NO· production (Fig. 2). IFN-
did not increase O2·– production by wild-type macrophages as measured by reduction of cytochrome c (Fig. 2), and only very modestly increased the antimicrobial activity of iNOS–/– macrophages (Fig. 1). Similar results were obtained for wild-type S. typhimurium American Type Culture Collection strain 14028s and wild-type strain M525P (data not shown).
|
|
–activated macrophages from wild-type, iNOS–/–, and gp91phox–/– mice was studied over a period of 14 h (Fig. 3). Macrophages from wild-type C57BL/6 mice exhibited pronounced bactericidal activity towards Salmonella during the first 6 h after challenge. In fact, these macrophages eliminated >99% of the original inoculum during the first 6 h of infection. At later time points, macrophages exhibited cytostatic behavior, confining the bacterial burden to a steady level. Although the NADPH oxidase contributed more than iNOS to overall macrophage antimicrobial activity, substantial temporal differences were observed in the contribution of these systems. Macrophages deficient in the NADPH oxidase did not reduce the original inoculum, but were still able to maintain the bacterial burden at a steady level over time (Fig. 3 A). In contrast, macrophages deficient in iNOS considerably reduced the initial inoculum but were unable to control bacterial replication at later time points (Fig. 3 B). The contribution of iNOS to macrophage antibacterial activity was detectable as early as 2 h after the initial challenge (P < 0.05), but became more substantial over time.
|
Production of ROS and RNS in Response to Salmonella.
Production of ROS and RNS by IFN-
–activated macrophages from wild-type, iNOS–/–, and gp91phox–/– mice was determined over a 10-h period by chemiluminescence using lucigenin and luminol, and by spectrophotometry using the Griess reagent (Fig. 4). Production of ROS by macrophages from wild-type mice was initiated immediately after phagocytosis, decreasing to undetectable levels by 6 h thereafter (Fig. 4 A). Lucigenin-dependent chemiluminescence was three times lower than that mediated by luminol (Fig. 4A and Fig. B), suggesting that a substantial proportion of the O2·– formed by the NADPH oxidase reacts with NO· to form ONOO–. As anticipated, macrophages from phox–/– mice exhibited neither lucigenin- nor luminol-dependent chemiluminescence. Macrophages from iNOS–/– mice showed a considerable diminution in luminol-dependent chemiluminescence. However, these macrophages generated a prolonged lucigenin-dependent chemiluminescence that persisted for the duration of the experiment.
|
The relative abundance of ROS and RNS produced by macrophages during the first hour after challenge with S. typhimurium strain 14028s was characterized further (Fig. 5). Of the ROS measured, H2O2 was the most abundant, accounting for
0.15 ± 0.01 nmol/h/105 macrophages, closely followed by O2·– (0.10 ± 0.01 nmol/h/105 macrophages; Fig. 5A and Fig. B). Macrophages from iNOS–/– mice produced more O2·– and H2O2 in response to Salmonella infection than those from wild-type control animals (P < 0.05). Macrophages from iNOS–/– mice appeared to produce very low levels of NOx that almost exclusively consisted of NO3– (Fig. 5C and Fig. E), suggesting that a significant proportion of the NO· attributed to constitutive NOS might react with O2·– to form ONOO– (Fig. 4 B). Macrophages from gp91phox–/– mice did not produce detectable quantities of O2·–, H2O2, or chemiluminescence.
|
0.4 nmol/h/105 macrophages of NOX was produced (Fig. 5 C). The majority of the NO· was oxidized to NO3– (
0.3 nmol/h/105 macrophages), although a third was metabolized to NO2– (Fig. 5D and Fig. E). After 10 h of infection, the macrophages increased their production of both NO3– and NO2–. NO3– production greatly exceeded that of NO2– in wild-type, iNOS–/–, and gp91phox–/– macrophages. NO· synthesized by constitutive NOS appear to have a negligible contribution to macrophage antimicrobial activity, as the NOS inhibitor NG-monomethyl L-arginine did not reduce the inhibition of Salmonella by macrophages from iNOS–/– mice (data not shown).
Nitrotyrosine Formation in Salmonella-infected Macrophages.
To determine whether ONOO– produced by macrophages targets intracellular Salmonella, formation of nitrotyrosine, a product that can be formed from the reaction of ONOO– with tyrosine residues, was investigated by immunofluorescence microscopy (Fig. 6). In agreement with the biochemical data (Fig. 4), nitrotyrosine was present in wild-type macrophages infected with wild-type S. typhimurium, but absent from NADPH oxidase–deficient control macrophages (Fig. 6A and Fig. C). The presence of nitrotyrosine was markedly reduced, but not totally absent, in macrophages from iNOS–/– mice (Fig. 6 B). Nitrotyrosine labeling failed to colocalize with green fluorescent protein (GFP)-tagged Salmonella in any instance (Fig. 6A and Fig. B), suggesting that ONOO– is formed but may not contribute to bacterial killing. In further support of this notion, the scavenger uric acid did not diminish, but rather enhanced by twofold the bactericidal activity of wild-type macrophages (Fig. 7), suggesting that formation of ONOO– is actually detrimental to macrophage anti-Salmonella activity.
|
|
| Discussion |
|---|
|
|
|---|
NO·-dependent anti-Salmonella activity was demonstrable in both untreated and IFN-
–treated macrophages, suggesting that bacterial products such as LPS and DNA 45 can trigger sufficient NO· synthesis to exert antimicrobial activity, at least in partially activated peritoneal cells elicited by sodium periodate. Nevertheless, the addition of IFN-
enhances macrophage anti-Salmonella activity predominantly by increasing NO· production (Fig. 1 and Fig. 2).
Although ROS and RNS can exert synergistic antimicrobial actions 1417181925, they principally act in sequential fashion in assays of macrophages infected with Salmonella. An early phase of rapid oxidative killing occurs during the peak respiratory burst, followed by a nitrosative bacteriostatic phase (Fig. 3 and Fig. 4). The functional separation of these two phases of antimicrobial activity is illustrated by the capacity of macrophages deficient in the NADPH oxidase to maintain their bacterial load at a steady level despite an inability to reduce the original inoculum. In contrast, congenic iNOS-deficient macrophages retained early bacterial killing but were unable to maintain control of subsequent bacterial replication over time. These temporal differences in the antimicrobial behavior of macrophages were paralleled by the early detection of oxidative products followed by a later rise in nitrogen oxides (Fig. 4). The respiratory burst of infected macrophages peaked shortly after phagocytosis, decreasing rapidly thereafter. The brief duration of the respiratory burst may result in part from direct inhibition of NADPH oxidase assembly by NO· congeners 46474849, as macrophages from iNOS–/– mice sustained a more prolonged respiratory burst. Additionally, the increasing abundance of nitrogen oxides over time may be quenching the oxidative chemistry of O2·– and ONOO– 5051.
The sequential, functionally distinct, and essential roles of ROS and RNS in Salmonella killing or inhibition by macrophages contrast with earlier studies of Leishmania, in which ROS did not appear to play a role 52. Studies of Listeria killing by macrophages have yielded somewhat conflicting results, with various investigators reporting that antilisterial activity is RNS independent 953, ROS dependent 9, or either RNS or ROS dependent depending on the timing of activation 54.
S. typhimurium killing by macrophages appears to be completely dependent upon the NADPH oxidase. H2O2 is likely to make a major contribution to bacterial killing, as it diffuses rapidly through membranes and reacts with transition metals to form highly toxic hydroxyl radicals. O2·– has also been implicated by observations that sodC mutant bacteria deficient in periplasmic Cu,Zn-superoxide dismutase are hypersusceptible to macrophage killing and exhibit reduced virulence 255556.
NO· makes a relatively minor contribution to early macrophage oxidative killing (Fig. 3). ONOO–, a reactive molecule capable of mediating 1- and 2-electron oxidations 16 with potent in vitro microbicidal activity for E. coli, S. typhimurium, and C. albicans 171825, might account for this activity. However, intracellular bacteria fail to colocalize with nitrotyrosine (Fig. 6), a molecular signature that can be associated with ONOO– synthesis 1542, suggesting that ONOO– may not be responsible for early bactericidal effects. The scavenger uric acid actually potentiates Salmonella killing (Fig. 7), further indicating that ONOO– production by Salmonella-containing macrophages may be responsible for host cell autotoxicity rather than antimicrobial activity. Synergistic actions of metal ions, NO· redox congeners, and H2O2, or the production of singlet oxygen from the reaction of NO· and H2O2, are alternative mechanisms by which NO·-derived species may potentiate NADPH oxidase–dependent macrophage killing 195758.
At this time, the identity of the nitrogen oxides responsible for the sustained NO·-dependent inhibition of bacterial growth are not known, but possibilities include NO· itself, N2O3, and S-nitrosothiols, which have been shown to exert bacteriostatic activity for S. typhimurium in vitro 1314. The predominant accumulation of NO3– rather than NO2– at late time points in the macrophage assay when ONOO– is no longer detectable suggests that dioxygenase activity 59 might be involved in NO· oxidation.
Of the three NOS isoforms that can catalyze the enzymatic production of NO·, iNOS is most closely associated with antimicrobial activity. The contribution of cNOS to the antibacterial activity of macrophages in this study was negligible. The small quantity of NO· attributed to cNOS was oxidized to NO3– (
0.12 nmol/h/105 macrophages). A small amount of nitrotyrosine staining and NOx production detectable in iNOS-deficient macrophages infected with Salmonella suggests that NO· derived from cNOS can react with O2·–, as has been demonstrated in murine Mycoplasma pulmonis infection 60. These results might indicate that murine mononuclear phagocytes are able to express both inducible and constitutive NOS, as has been suggested by others 6162, although functional cNOS has not yet been definitively demonstrated in primary murine peritoneal macrophages.
In conclusion, both the NADPH phagocyte oxidase and iNOS contribute to the ability of macrophages to inhibit or kill S. typhimurium. Analysis of murine peritoneal macrophages reveals a temporally coordinated action of ROS and RNS. Rapid bacterial killing coinciding with production of O2·– by the NADPH phagocyte oxidase is followed by a prolonged period of inhibition of bacterial growth associated with the production of iNOS-derived nitrosative species. The sequential roles of oxidative and nitrosative phagocyte antimicrobial mediators in vitro are mirrored by the temporal relationship of early NADPH oxidase–dependent and late iNOS-dependent antimicrobial effector mechanisms observed during murine Salmonella infection in vivo 10.
| Acknowledgments |
|---|
This work was supported by National Institutes of Health (NIH) postdoctoral fellowship AI10181, NIH grants AI39557 and AI44486, the James Biundo Foundation, the Wellcome Trust, and Biotechnology and Biological Sciences Research Council.
Submitted: 21 January 2000
Revised: 25 April 2000
Accepted: 5 May 2000
| References |
|---|
|
|
|---|
Vazquez-Torres A., Jones-Carson J., Baumler A.J., Falkow S., Valdivia R., Brown W., Le M., Berggren R., Parks W.T. & Fang F.C.. Extraintestinal dissemination of Salmonella via CD18-expressing phagocytes, Nature., 401, 1999, 804–808.[Medline]
Vazquez-Torres A. & Fang F.C.. Cellular routes of invasion by enteropathogens, Curr. Opin. Microbiol, 3, 2000, 54–59.[Medline]
Richter-Dahlfors A., Buchan A.M.J. & Finlay B.B.. Murine salmonellosis studied by confocal microscopySalmonella typhimurium resides intracellularly inside macrophages and exerts a cytotoxic effect on phagocytes in vivo, J. Exp. Med, 186, 1997, 569–580.
Fields P.I., Swanson R.V., Haidaris C.G. & Heffron F.. Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent, Proc. Natl. Acad. Sci. USA, 83, 1986, 5189–5193.
Mackaness G.B.. Cellular resistance to infection, J. Exp. Med., 116, 1962, 381–406.[Abstract]
Miller R.A. & Britigan B.E.. Role of oxidants in microbial pathophysiology, Clin. Microbiol. Rev, 10, 1997, 1–18.[Abstract]
Curnutte J.T., Scott P.J. & Babior B.M.. Functional defect in neutrophil cytosols from two patients with autosomal recessive cytochrome-positive chronic granulomatous disease, J. Clin. Invest, 83, 1989, 1236–1240.[Medline]
Mouy R., Fischer A., Vilmer E., Seger R. & Griscelli C.. Incidence, severity, and prevention of infections in chronic granulomatous disease, J. Pediatr, 114, 1989, 555–560.[Medline]
Shiloh M.U., MacMicking J.D., Nicholson S., Brause J.E., Potter S., Marino M., Fang F., Dinauer M. & Nathan C.. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase, Immunity, 10, 1999, 29–38.[Medline]
Mastroeni P., Vazquez-Torres A., Fang F.C., Xu Y., Khan S., Hormaeche C.E. & Dougan G.. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo, J. Exp. Med., 192, 2000, 237–247.
Buchmeier N.A., Lipps C.J., So M.Y. & Heffron F.. Recombination-deficient mutants of Salmonella typhimurium are avirulent and sensitive to the oxidative burst of macrophages, Mol. Microbiol, 7, 1993, 933–936.[Medline]
MacMicking J., Xie Q.W. & Nathan C.. Nitric oxide and macrophage function, Annu. Rev. Immunol, 15, 1997, 323–350.[Medline]
De Groote M.A., Granger D., Xu Y., Campbell G., Prince R. & Fang F.C.. Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model, Proc. Natl. Acad. Sci. USA., 92, 1995, 6399–6403.
Fang F.C.. Perspectives serieshost/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity, J. Clin. Invest, 99, 1997, 2818–2825.[Medline]
Ischiropoulos H., Zhu L. & Beckman J.S.. Peroxynitrite formation from macrophage-derived nitric oxide, Arch. Biochem. Biophys, 298, 1992, 446–451.[Medline]
Pryor W.A. & Squadrito G.L.. The chemistry of peroxynitritea product from the reaction of nitric oxide with superoxide, Am. J. Physiol, 268, 1995, L699–L722.[Medline]
Zhu L., Gunn C. & Beckman J.S.. Bactericidal activity of peroxynitrite, Arch. Biochem. Biophys, 298, 1992, 452–457.[Medline]
Vazquez-Torres A., Jones-Carson J. & Balish E.. Peroxynitrite contributes to the candidacidal activity of nitric oxide-producing macrophages, Infect. Immun, 64, 1996, 3127–3133.[Abstract]
Pacelli R., Wink D.A., Cook J.A., Krishna M.C., DeGraff W., Friedman N., Tsokos M., Samuni A. & Mitchell J.B.. Nitric oxide potentiates hydrogen peroxide–induced killing of Escherichia coli, J. Exp. Med., 182, 1995, 1469–1479.
Bogdan C., Röllinghoff M. & Diefenbach A.. Nitric oxide in Leishmaniasisfrom antimicrobial activity to immunoregulation, Fang F.C.. Nitric Oxide and Infection, 1999, 361–377, Kluwer Academic/Plenum Publishers, New York.
Chan J. & Flynn J.. Nitric oxide in Mycobacterium tuberculosis infection, Fang F.C.. Nitric Oxide and Infection, 1999, 281–310, Kluwer Academic/Plenum Publishers, New York.
Mastroeni P., Harrison J.A., Robinson J.H., Clare S., Khan S., Maskell D.J., Dougan G. & Hormaeche C.E.. Interleukin-12 is required for control of the growth of attenuated aromatic-compound-dependent Salmonellae in BALB/c micerole of gamma interferon and macrophage activation, Infect. Immun, 66, 1998, 4767–4776.
Mastroeni P., Skepper J.N. & Hormaeche C.E.. Effect of anti-tumor necrosis factor alpha antibodies on histopathology of primary Salmonella infections, Infect. Immun, 63, 1995, 3674–3682.[Abstract]
Saito S., Onozuka K., Shinomiya H. & Nakano M.. Sensitivity of bacteria to NaNO2 and to L-arginine-dependent system in murine macrophages, Microbiol. Immunol, 35, 1991, 325–329.[Medline]
De Groote M.A., Ochsner U.A., Shiloh M.U., Nathan C., McCord J.M., Dinauer M.C., Libby S.J., Vazquez-Torres A., Xu Y. & Fang F.C.. Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase, Proc. Natl. Acad. Sci. USA., 94, 1997, 13997–14001.
Chen L., Xie Q.W. & Nathan C.. Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates, Mol. Cell, 1, 1998, 795–805.[Medline]
Kosaka H., Oda Y. & Uozumi M.. Induction of umuC gene expression by nitrogen dioxide in Salmonella typhimurium, Mutat. Res, 142, 1985, 99–102.[Medline]
De Groote M.A., Testerman T., Xu Y., Stauffer G. & Fang F.C.. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium, Science, 272, 1996, 414–417.[Abstract]
Crawford M.J. & Goldberg D.E.. Role for the Salmonella flavohemoglobin in protection from nitric oxide, J. Biol. Chem, 1273, 1998, 12543–12547.[Medline]
Shiloh M.U., Ruan J. & Nathan C.. Evaluation of bacterial survival and phagocyte function with a fluorescence-based microplate assay, Infect. Immun, 65, 1997, 3193–3198.[Abstract]
Ekman P., Saarinen M., He Q., Virtala M., Salmi M. & Granfors K.. Human monocytic U937 cells kill Salmonella in vitro by NO-independent mechanisms, Infect. Immun, 67, 1999, 3670–3673.
Mastroeni P., Villarreal-Ramos B. & Hormaeche C.E.. Effect of late administration of anti-TNF
antibodies on a Salmonella infection in the mouse model, Microb. Pathog, 14, 1993, 473–480.[Medline]
MacMicking J.D., Nathan C., Hom G., Chartrain N., Fletcher D.S., Trumbauer M., Stevens K., Xie Q.W., Sokol K. & Hutchinson N.. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase, Cell, 81, 1995, 641–650.[Medline]
Pollock J.D., Williams D.A., Gifford M.A., Li L.L., Du X., Fisherman J., Orkin S.H., Doerschuk C.M. & Dinauer M.C.. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production, Nat. Genet, 9, 1995, 202–209.[Medline]
Li Y., Zhu H., Kuppusamy P., Roubaud V., Zweier J.L. & Trush M.A.. Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems, J. Biol. Chem, 273, 1998, 2015–2023.
Radi R., Cosgrove T.P., Beckman J.S. & Freeman B.A.. Peroxynitrite-induced luminol chemiluminescence, Biochem. J, 290, 1993, 51–57.[Medline]
Hooper D.C., Spitsin S., Kean R.B., Champion J.M., Dickson G.M., Chaudhry I. & Koprowski H.. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis, Proc. Natl. Acad. Sci. USA., 95, 1998, 675–680.
Szabo C. & Salzman A.L.. Endogenous peroxynitrite is involved in the inhibition of mitochondrial respiration in immuno-stimulated J774.2 macrophages, Biochem. Biophys. Res. Commun, 209, 1995, 739–743.[Medline]
Pick E.. Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassay microplate reader, Methods Enzymol, 132, 1986, 407–421.[Medline]
Gilliam M.B., Sherman M.P., Griscavage J.M. & Ignarro L.J.. A spectrophotometric assay for nitrate using NADPH oxidation by Aspergillus nitrate reductase, Anal. Biochem, 12, 1993, 359–365.
Verdon C.P., Burton B.A. & Prior R.L.. Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite, Anal. Biochem, 224, 1995, 502–508.[Medline]
Crow J.P. & Ischiropoulos H.. Detection and quantitation of nitrotyrosine residues in proteinsin vivo marker of peroxynitrite, Methods Enzymol, 269, 1996, 185–194.[Medline]
MacFarlane A.S., Schwacha M.G. & Eisenstein T.K.. In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen, Infect. Immun, 67, 1999, 891–898.
al-Ramadi B.K., Meissler J.J. Jr., Huang D. & Eisenstein T.K.. Immunosuppression induced by nitric oxide and its inhibition by interleukin-4, Eur. J. Immunol, 22, 1992, 2249–2254.[Medline]
Gao J.J., Zuvanich E.G., Xue Q., Horn D.L., Silverstein R. & Morrison D.C.. Cutting edgebacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages, J. Immunol, 163, 1999, 4095–4099.
Clancy R.M., Leszczynska-Piziak J. & Abramson S.B.. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase, J. Clin. Invest, 90, 1992, 1116–1121.[Medline]
Iha S., Orita K., Utsumi T., Sato E.F., Inoue M. & Utsumi K.. Oxygen-dependent inhibition of neutrophil respiratory burst by nitric oxide, Free Radic. Res., 25, 1996, 489–498.[Medline]
Forslund T. & Sundqvist T.. Nitric oxide reduces hydrogen peroxide production from human polymorphonuclear neutrophils, Eur. J. Clin. Invest, 25, 1995, 9–14.[Medline]
Fujii H., Ichimori K., Hoshiai K. & Nakazawa H.. Nitric oxide inactivates NADPH oxidase in pig neutrophils by inhibiting its assembling process, J. Biol. Chem, 272, 1997, 32773–32778.
Wink D.A., Cook J.A., Kim S.Y., Vodovotz Y., Pacelli R., Krishna M.C., Russo A., Mitchell J.B., Jourd'heuil D., Miles A.M. & Grisham M.B.. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress, J. Biol. Chem, 272, 1997, 11147–11151.
Wink D.A., Vodovotz Y., Grisham M.B., DeGraff W., Cook J.C., Pacelli R., Krishna M. & Mitchell J.B.. Antioxidant effects of nitric oxide, Methods Enzymol, 301, 1999, 413–424.[Medline]
Assreuy J., Cunha F.Q., Epperlein M., Noronha-Dutra A., O'Donnell C.A., Liew F.Y. & Moncada S.. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major, Eur. J. Immunol., 24, 1994, 672–676.[Medline]
Leenen P.J., Canono B.P., Drevets D.A., Voerman J.S. & Campbell P.A.. TNF-alpha and IFN-gamma stimulate a macrophage precursor cell line to kill Listeria monocytogenes in a nitric oxide-independent manner, J. Immunol., 153, 1994, 5141–5147.[Abstract]
Ohya S., Tanabe Y., Makino M., Nomura T., Xiong H., Arakawa M. & Mitsuyama M.. The contributions of reactive oxygen intermediates and reactive nitrogen intermediates to listericidal mechanisms differ in macrophages activated pre- and postinfection, Infect. Immun., 66, 1998, 4043–4049.
Fang F.C., DeGroote M.A., Foster J.W., Baumler A.J., Ochsner U., Testerman T., Bearson S., Giard J.C., Xu Y., Campbell G. & Laessig T.. Virulent Salmonella typhimurium has two periplasmic Cu, Zn-superoxide dismutases, Proc. Natl. Acad. Sci. USA., 96, 1999, 7502–7507.
Farrant J.L., Sansone A., Canvin J.R., Pallen M.J., Langford P.R., Wallis T.S., Dougan G. & Kroll J.S.. Bacterial copper- and zinc-cofactored superoxide dismutase contributes to the pathogenesis of systemic salmonellosis, Mol. Microbiol, 25, 1997, 785–796.[Medline]
Noronha-Dutra A.A., Epperlein M.M. & Woolf N.. Reaction of nitric oxide with hydrogen peroxide to produce potentially cytotoxic singlet oxygen as a model for nitric oxide–mediated killing, FEBS Lett., 321, 1993, 59–62.[Medline]
Chazotte-Aubert L., Oikawa S., Gilibert I., Vianchini F., Kawanishi S. & Ohshima H.. Cytotoxicity and site-specific DNA damage induced by nitroxyl anion (NO–) in the presence of hydrogen peroxide, J. Biol. Chem, 274, 1999, 20909–20915.
Hausladen A., Gow A.J. & Stamler J.S.. Nitrosative stressmetabolic pathway involving the flavohemoglobin, Proc. Natl. Acad. Sci. USA., 95, 1998, 14100–14105.
Hickman-Davis J., Gibbs-Erwin J., Lindsey J.R. & Matalon S.. Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite, Proc. Natl. Acad. Sci. USA., 96, 1999, 4953–4958.
Schmidt H.H., Warner T.D., Nakane M., Forstermann U. & Murad F.. Regulation and subcellular location of nitrogen oxide synthases in RAW264.7 macrophages, Mol. Pharmacol, 41, 1992, 615–624.[Abstract]
Hecker M., Walsh D.T. & Vane J.R.. Characterization of a microsomal calcium-dependent nitric oxide synthase in activated J774.2 monocyte/macrophages, J. Cardiovasc. Pharmacol, 20Suppl. 121992, S139–S141.[Medline]
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| TABLE OF CONTENTS |
|